These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12835231)

  • 1. Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection.
    Cilloni D; Gottardi E; Fava M; Messa F; Carturan S; Busca A; Guerrasio A; Saglio G
    Blood; 2003 Jul; 102(2):773-4; author reply 774. PubMed ID: 12835231
    [No Abstract]   [Full Text] [Related]  

  • 2. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia.
    Ogawa H; Tamaki H; Ikegame K; Soma T; Kawakami M; Tsuboi A; Kim EH; Hosen N; Murakami M; Fujioka T; Masuda T; Taniguchi Y; Nishida S; Oji Y; Oka Y; Sugiyama H
    Blood; 2003 Mar; 101(5):1698-704. PubMed ID: 12406915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia.
    Xu B; Song X; Yip NC; Xiao P; Zhang Y; Wang W; Zhou S
    Hematology; 2010 Apr; 15(2):74-80. PubMed ID: 20423567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia.
    Tamaki H; Ogawa H; Inoue K; Soma T; Yamagami T; Miyake S; Oka Y; Oji Y; Tatekawa T; Tsuboi A; Tagawa S; Kitani T; Aozasa K; Kishimoto T; Sugiyama H; Miwa H; Kita K
    Blood; 1996 Dec; 88(11):4396-8. PubMed ID: 8943879
    [No Abstract]   [Full Text] [Related]  

  • 5. Wilms' tumor gene 1 expression analysis by real-time quantitative polymerase chain reaction for monitoring of minimal residual disease in acute leukemia.
    Nowakowska-Kopera A; Sacha T; Florek I; Zawada M; Czekalska S; Skotnicki AB
    Leuk Lymphoma; 2009 Aug; 50(8):1326-32. PubMed ID: 19811333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WT1 protein expression in childhood acute leukemia.
    Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I
    Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of WT1 gene in multiple myeloma patients at diagnosis: is WT1 gene expression a useful marker in multiple myeloma?
    Saatci C; Caglayan AO; Kocyigit I; Akalin H; Kaynar LG; Altuntas F; Eser B; Demir M; Cetin M; Ozkul Y
    Hematology; 2010 Feb; 15(1):39-42. PubMed ID: 20132661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study.
    Willasch AM; Gruhn B; Coliva T; Kalinova M; Schneider G; Kreyenberg H; Steinbach D; Weber G; Hollink IH; Zwaan CM; Biondi A; van der Velden VH; Reinhardt D; Cazzaniga G; Bader P; Trka J;
    Leukemia; 2009 Aug; 23(8):1472-9. PubMed ID: 19322206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WT1 Expression in Circulating RNA as a Minimal Residual Disease Marker for AML Patients After Stem-Cell Transplantation.
    Zhong L; Wei L; Chen J; Huang X; Gong Y; Lu Y
    Mol Diagn Ther; 2015 Aug; 19(4):205-12. PubMed ID: 26138637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia.
    Inoue K; Ogawa H; Sonoda Y; Kimura T; Sakabe H; Oka Y; Miyake S; Tamaki H; Oji Y; Yamagami T; Tatekawa T; Soma T; Kishimoto T; Sugiyama H
    Blood; 1997 Feb; 89(4):1405-12. PubMed ID: 9028964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.
    Messina C; Candoni A; Carrabba MG; Tresoldi C; Sala E; Tassara M; Crippa A; Peccatori J; Assanelli A; Gattillo S; Bellio L; Fanin R; Ciceri F; Bernardi M
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1586-91. PubMed ID: 24954546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of WT1 as a reliable tool for the detection of minimal residual disease in children with leukemia.
    Kletzel M; Olzewski M; Huang W; Chou PM
    Pediatr Dev Pathol; 2002; 5(3):269-75. PubMed ID: 12007019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.
    Candoni A; De Marchi F; Zanini F; Zannier ME; Simeone E; Toffoletti E; Chiarvesio A; Cerno M; Filì C; Patriarca F; Fanin R
    Exp Hematol; 2017 May; 49():25-33. PubMed ID: 28159598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis of leukemic cells by TRUE gene silencing using small guide RNAs targeting the WT1 mRNA.
    Watanabe N; Narita M; Yamahira A; Taniguchi T; Furukawa T; Yoshida T; Miyazawa T; Nashimoto M; Takahashi M
    Leuk Res; 2013 May; 37(5):580-5. PubMed ID: 23403166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluorescence quantitative PCR detection of WT1 gene expression in peripheral blood of patients with acute leukemias and its clinical implications].
    Bai B; Wang HW; Xu YQ; Yang HN; Qiao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):610-4. PubMed ID: 16129044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms tumor gene (WT1) expression as a panleukemic marker.
    Menssen HD; Siehl JM; Thiel E
    Int J Hematol; 2002 Aug; 76(2):103-9. PubMed ID: 12215007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol.
    Gaiger A; Linnerth B; Mann G; Schmid D; Heinze G; Tisljar K; Haas OA; Gadner H; Lion T
    Eur J Haematol; 1999 Aug; 63(2):86-93. PubMed ID: 10480287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity.
    Zhao XS; Yan CH; Liu DH; Xu LP; Liu YR; Liu KY; Qin YZ; Wang Y; Huang XJ
    Ann Hematol; 2013 Aug; 92(8):1111-9. PubMed ID: 23680867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WT1 mRNA level in peripheral blood is a sensitive biomarker for monitoring minimal residual disease in acute myeloid leukemia.
    Sakamoto Y; Mariya Y; Sasaki S; Teshiromori R; Oshikiri T; Segawa M; Ogura K; Akagi T; Kubo K; Kaimori M; Funato T
    Tohoku J Exp Med; 2009 Oct; 219(2):169-76. PubMed ID: 19776535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of minimal residual disease by assessing Wilms tumor gene expression and engraftment by variable number of tandem repeats in children with leukemia posthematopoietic stem cell transplantation.
    Olszewski M; Chou PM; Huang W; Tallman S; Kletzel M
    Pediatr Dev Pathol; 2006; 9(3):203-9. PubMed ID: 16944968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.